Travere Therapeutics Inc (TVTX) Insider Trading
Total insider buys:
- $0.00
Total insider sells:
- $13,028,199.72
Most recent insider trade:
- Feb. 12, 2025
Most active insider trader:
- Eric M Dube
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Feb. 1, 2023 | SVP | 2,590 | $22.25 | Sell | $57,627.50 | |
Feb. 1, 2023 | CAO | 1,671 | $21.75 | Sell | $36,344.25 | |
Jan. 24, 2023 | CAO | 905 | $21.90 | Sell | $19,819.50 | |
Jan. 24, 2023 | CFO | 852 | $21.90 | Sell | $18,658.80 | |
Jan. 24, 2023 | CEO | 6,442 | $21.50 | Sell | $138,503.00 | |
Jan. 24, 2023 | Insider | 1,550 | $21.90 | Sell | $33,945.00 | |
Jan. 24, 2023 | SVP | 2,062 | $21.50 | Sell | $44,333.00 | |
Jan. 5, 2023 | CEO | 5,625 | $20.75 | Sell | $116,718.75 | |
Jan. 4, 2023 | Insider | 2,051 | $20.75 | Sell | $42,558.25 | |
Oct. 4, 2022 | Insider | 3,042 | $25.68 | Sell | $78,118.56 | |
Sept. 13, 2022 | CAO | 349 | $28.00 | Sell | $9,772.00 | |
May 11, 2022 | Director | 2,575 | $21.92 | Sell | $56,444.00 | |
May 11, 2022 | SVP | 1,563 | $21.71 | Sell | $33,932.73 | |
May 10, 2022 | CFO | 825 | $21.51 | Sell | $17,745.75 | |
May 10, 2022 | CAO | 436 | $21.51 | Sell | $9,378.36 | |
Jan. 31, 2022 | CFO | 1,238 | $27.40 | Sell | $33,921.20 | |
Jan. 31, 2022 | CAO | 798 | $26.51 | Sell | $21,154.98 | |
Jan. 31, 2022 | Insider | 1,125 | $27.40 | Sell | $30,825.00 | |
Jan. 31, 2022 | CEO | 4,813 | $27.40 | Sell | $131,876.20 | |
Jan. 31, 2022 | SVP | 1,350 | $27.40 | Sell | $36,990.00 | |
Jan. 24, 2022 | CEO | 7,873 | $24.98 | Sell | $196,667.54 | |
Jan. 24, 2022 | SVP | 1,875 | $24.98 | Sell | $46,837.50 | |
Jan. 24, 2022 | CAO | 934 | $24.58 | Sell | $22,957.72 | |
Jan. 24, 2022 | CFO | 2,063 | $24.98 | Sell | $51,533.74 | |
Jan. 11, 2022 | SVP | 5,000 | $27.40 | Sell | $137,000.00 | |
Jan. 11, 2022 | CFO | 7,500 | $27.40 | Sell | $205,500.00 | |
Jan. 4, 2022 | CEO | 4,832 | $30.43 | Sell | $147,037.76 | |
Nov. 16, 2021 | Director | 31,800 | $29.39 | Sell | $934,602.00 | |
Nov. 5, 2021 | Director | 10,000 | $26.23 | Sell | $262,300.00 | |
Oct. 7, 2021 | Director | 60,000 | $26.25 | Sell | $1,575,000.00 | |
Aug. 17, 2021 | Insider | 1,407 | $17.12 | Sell | $24,087.84 | |
Aug. 17, 2021 | CEO | 7,836 | $17.12 | Sell | $134,152.32 | |
July 28, 2021 | Insider | 1,250 | $13.81 | Sell | $17,262.50 | |
June 2, 2021 | CEO | 9,562 | $14.62 | Sell | $139,796.44 | |
April 16, 2021 | Director | 10,000 | $26.23 | Sell | $262,300.00 | |
March 17, 2021 | Director | 17,727 | $27.44 | Sell | $486,428.88 | |
Feb. 18, 2021 | SVP | 2,500 | $28.01 | Sell | $70,025.00 | |
Feb. 3, 2021 | Insider | 1,813 | $28.91 | Sell | $52,413.83 | |
Feb. 3, 2021 | CFO | 3,625 | $28.91 | Sell | $104,798.75 | |
Feb. 3, 2021 | SVP | 3,175 | $28.91 | Sell | $91,789.25 | |
Feb. 3, 2021 | CEO | 2,406 | $28.91 | Sell | $69,557.46 |
Insiders are selling Travere Therapeutics Inc stock.
The insider traders at Travere Therapeutics Inc are: Eric M Dube, Sandra Calvin, Christopher R Cline, William E Rote, Peter Heerma, Jula Inrig, Elizabeth E Reed, Steve Aselage, Laura Clague, Roy D Baynes, Noah L. Rosenberg, Jeffrey A Meckler, Gary A Lyons, and Noah L Rosenberg
The most active insider trader at Travere Therapeutics Inc is Eric M Dube with 16 trades.
Steve Aselage has sold the most Travere Therapeutics Inc stock with a total value of $3,633,518.88.
The most recent insider trade for Travere Therapeutics Inc was on Feb. 12, 2025.
The single biggest insider sell for Travere Therapeutics Inc was from Steve Aselage with a total value of $1,575,000.00 on Oct. 7, 2021.